This isHOMEinCorporate InformationinCorporate Profilepages.

Corporate Profile


February 20, 1939


Manufacturing and sales of clinical diagnostics and equipments


6,897 million yen (March 31, 2019)

Stock Exchange Listings

First Section of the Tokyo Stock Exchange     code: 4549


Consolidated Results for the Year Ended

(millions of yen)
  March 31, 2017 March 31, 2018 March 31, 2019
Net sales 33,274 34,991 35,761
Operating income 3,976 3,478 4,611
Ordinary income 4,112 3,549 4,681
Net income 2,918 2,608 3,447

Directors        (June 26, 2018)

  1. Morifumi Wada
  2. Katsushi Abe
  3. Tsugunori Noutomi
  1. Takehisa Irisawa
  2. Kunio Uchiyamada
  3. Shigeru Nomura
  4. Yukiya Hakozaki
  5. Atsuoh Katsumata

Executive Officer    (June 26, 2018)

President & CEO Morifumi Wada
Vice President & Executive Officer Katsushi Abe
Vice President & Executive Officer Tsugunori Noutomi
Executive Officer Norihisa Noguchi
Executive Officer Shinya Sadamoto
Executive Officer Kazuhisa Ueda
Executive Officer Hiroshi Wada
Executive Officer Hajime Watari
Executive Officer Harufumi Tsuge
Executive Officer Naomichi Harada
Executive Officer Tomoyoshi Takahashi

Number of Employees

673 (March 31, 2019)

* Parent company only

Major Offices

4-19-9 Taito, Taito-ku, Tokyo, 110-8408, Japan

View Larger Map

* 4 minutes walk from JR Yamanote Line Okachimachi Sta.
* 3 minutes walk from Tokyo Metoro Hibiya Line Nakaokachimachi Sta.
* 5 minutes walk from Tokyo Metoro Ginza Line Uenohirokoji Sta.
* 5 minutes walk from Toei Oedo Line Shinokachimachi Sta.

Other Division

Europe Office
 Burgemeester Haspelslaan 25, 1181 NB Amstelveen, The Netherlands

Sales Office (Japan)
 Hokkaido-Tohoku, Tokyo Metropolitan Area Sales Dept.-Ⅰ, Kitakanto-Shinetsu, Tokyo Metro Politan Area Sales Dept.-Ⅱ, Tokai-Hokuriku, Kansai, Chugoku-Shikoku, Kyushu-Okinawa, Special Clinical Laboratory, Food Safety and Inspection Related Proucts

Nogi Division
 Factories, Research Laboratories

Nasu Division
  Factories, Research Laboratories